
Analysts Viewpoint
Potential Price Increase for Enliven Therapeutics Inc (ELVN) After Recent Insider Activity
In a filing, Enliven Therapeutics Inc revealed its CHIEF FINANCIAL OFFICER Hohl Benjamin unloaded Company’s shares for reported $22655.0 on